Organovo Holdings Company

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Total Funding: $117.4M
Headquarters: San Diego, California, United States
Funding Status: IPO
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Last Funding Type: Series E
Technology: Others
Investors Number: 2
Founded Date: 2007
Industry: PharmTech